Skip navigation
Skip navigation

Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial

Nelson, Mark; Abhayaratna, Walter; Grimm , R; ASPREE Investigator Group; Pressman, G.; Margolis, K.; Volpi, E.; McNeil, John J; Reid, Christopher M; Nelson, M R.; Stocks, Nigel; Ames, D; Beilin, Lawrence J


Cost-effective strategies to maintain healthy active lifestyle in aging populations are required to address the global burden of age-related diseases. ASPREE will examine whether the potential primary prevention benefits of low dose aspirin outweigh the risks in older healthy individuals. Our primary hypothesis is that daily oral 100. mg enteric-coated aspirin will extend a composite primary endpoint termed 'disability-free life' including onset of dementia, total mortality, or persistent...[Show more]

CollectionsANU Research Publications
Date published: 2013
Type: Journal article
Source: Contemporary Clinical Trials
DOI: 10.1016/j.cct.2013.09.014


File Description SizeFormat Image
01_Nelson_Study_design_of_ASPirin_in_2013.pdf276.7 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  23 August 2018/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator